Clinical Trials Open for Enrollment

DME DRCR AC

Aflibercept vs. Bevacizumab + Deferred Aflibercept

ELIGIBILITY

  • DM Type 1 or 2
  • Age 18 Years or Older
  • BCVA 20/50 – 20/320
  • OCT > 305 um in Women AND > 320 um in Men

END STAGE AMD VISION CARE

Implantable Telescope with End-Stage AMD

ELIGIBILITY

  • Age 65 years of Older
  • BCVA 20/160 – 20/800 in Both Eyes
  • Must be Pseudophakic in Study Eye
  • Agree to undergo Per and Post Vision Training with Low Vision Specialist

EXCLUSION

  • Cannot have had a Previous YAG
  • Cognitive Impairment that would interfere with Occupational Therapy
  • Evidence of Active CNV on Angiography or Activity within the Last 6 Months
  • Pathology Witch Would Compromise Fellow Eye Peripheral Vision

For any questions regarding the open clinical trials, please call us (505) EYE-SITE (505) 393-7483.